Glipizide Tablet, Extended Release
Product Images NDC 59651-780

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 59651-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (2.5 mg (30 Tablet Container))

This text is a mix of pharmaceutical information and some product details. It describes extended-release tablets of glipizide USP, which is used to treat diabetes. It also lists some important instructions for usage, including temperature control and protection from moisture and humidity. The package contains 30 tablets, and it will have a human-readable code that provides some key information about the product. The code is also printed using two-dimensional printing technology.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablet Container))

This text appears to be a label of a medication package. The medication is a NDC 50651-781-30 containing Gipide USP 5 mg by Aurobindo Pharma USA. The label contains dosage and usage instructions, as well as information about storage conditions. A prescribing information sheet is provided with the medication. The package comes with 30 extended-release tablets. The medication should be dispensed in tight containers and protected from moisture and humidity. The label also includes information about GTIN, serial number, expiry date and LOT printing during the packing process.*

FDA Label Image

Package Label-principal Display Panel (10 mg (30 Tablet Container))

This is a prescription medication called glipizide. It comes in the form of extended-release tablets and is manufactured by Aurobindo Pharma USA, Inc. Each pack contains 30 tablets. The recommended dosage and usage details are available in the accompanying prescribing information. The medication should be stored between 20°C to 25°C (68°F to 77°F) and protected from moisture and humidity. The NDC (National Drug Code) for this medication is 59651-782-30. The other information provided on the label includes manufacturing details and a unique serial and expiry date for the batch.*

FDA Label Image

Chemical Structure (Glipizide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.